$19.99
This report includes data from the FDA’s Adverse Events Reports for 2018. We removed reports where the subject of the report was taking only this drug. This report provides the following fields:
Aclasta contains zoledronic acid (sometimes called zoledronate). It belongs to a group of medicines called bisphosphonates. Zoledronic acid inhibits the release of calcium from bones. Aclasta is used to treats Paget’s disease and osteoporosis in postmenopausal women. Aclasta may also be used for other purposes not listed in this medication guide.https://www.drugs.com/aclasta.html
484-352-2642
The FDA Adverse Event Reporting System (FAERS) is a database that contains adverse event reports, medication error reports and product quality complaints resulting in adverse events that were submitted to FDA.